575 related articles for article (PubMed ID: 15306840)
21. Cross-inhibition to heterologous foot-and-mouth disease virus infection induced by RNA interference targeting the conserved regions of viral genome.
Liu M; Chen W; Ni Z; Yan W; Fei L; Jiao Y; Zhang J; Du Q; Wei X; Chen J; Liu Y; Zheng Z
Virology; 2005 May; 336(1):51-9. PubMed ID: 15866070
[TBL] [Abstract][Full Text] [Related]
22. Control of HIV-1 replication by RNA interference.
Lee NS; Rossi JJ
Virus Res; 2004 Jun; 102(1):53-8. PubMed ID: 15068880
[TBL] [Abstract][Full Text] [Related]
23. HIV envelope proteins differentially utilize CXCR4 and CCR5 coreceptors for induction of apoptosis.
Yao Q; Compans RW; Chen C
Virology; 2001 Jun; 285(1):128-37. PubMed ID: 11414813
[TBL] [Abstract][Full Text] [Related]
24. Down-regulation of CXCR4 expression in MT4 cells by a recombinant vector expressing antisense RNA to CXCR4 and its potential anti-HIV-1 effect.
Xing HC; Xu XY; Liu Z; Wang QH; Yu M; Si CW
Jpn J Infect Dis; 2004 Jun; 57(3):91-6. PubMed ID: 15218216
[TBL] [Abstract][Full Text] [Related]
25. HIV-1 coreceptor activity of CCR5 and its inhibition by chemokines: independence from G protein signaling and importance of coreceptor downmodulation.
Alkhatib G; Locati M; Kennedy PE; Murphy PM; Berger EA
Virology; 1997 Aug; 234(2):340-8. PubMed ID: 9268166
[TBL] [Abstract][Full Text] [Related]
26. Primary SIVsm isolates use the CCR5 coreceptor from sooty mangabeys naturally infected in west Africa: a comparison of coreceptor usage of primary SIVsm, HIV-2, and SIVmac.
Chen Z; Gettie A; Ho DD; Marx PA
Virology; 1998 Jun; 246(1):113-24. PubMed ID: 9656999
[TBL] [Abstract][Full Text] [Related]
27. Differences in molecular evolution between switch (R5 to R5X4/X4-tropic) and non-switch (R5-tropic only) HIV-1 populations during infection.
Mild M; Kvist A; Esbjörnsson J; Karlsson I; Fenyö EM; Medstrand P
Infect Genet Evol; 2010 Apr; 10(3):356-64. PubMed ID: 19446658
[TBL] [Abstract][Full Text] [Related]
28. RNA interference as a tool for exploring HIV-1 robustness.
Nevot M; Martrus G; Clotet B; Martínez MA
J Mol Biol; 2011 Oct; 413(1):84-96. PubMed ID: 21875599
[TBL] [Abstract][Full Text] [Related]
29. Targeting CCR5 with siRNAs: using recombinant SV40-derived vectors to protect macrophages and microglia from R5-tropic HIV.
Cordelier P; Morse B; Strayer DS
Oligonucleotides; 2003; 13(5):281-94. PubMed ID: 15000819
[TBL] [Abstract][Full Text] [Related]
30. Potent suppression of HIV type 1 infection by a short hairpin anti-CXCR4 siRNA.
Anderson J; Banerjea A; Planelles V; Akkina R
AIDS Res Hum Retroviruses; 2003 Aug; 19(8):699-706. PubMed ID: 13678472
[TBL] [Abstract][Full Text] [Related]
31. Antibody-mediated delivery of siRNAs for anti-HIV therapy.
Kim SS; Subramanya S; Peer D; Shimaoka M; Shankar P
Methods Mol Biol; 2011; 721():339-53. PubMed ID: 21431696
[TBL] [Abstract][Full Text] [Related]
32. The two human CXCR4 isoforms display different HIV receptor activities: consequences for the emergence of X4 strains.
Duquenne C; Psomas C; Gimenez S; Guigues A; Carles MJ; Barbuat C; Lavigne JP; Sotto A; Reynes J; Guglielmi P; Mettling C; François V; Corbeau P
J Immunol; 2014 Oct; 193(8):4188-94. PubMed ID: 25230750
[TBL] [Abstract][Full Text] [Related]
33. Suppression of chemokine receptor expression by RNA interference allows for inhibition of HIV-1 replication.
Martínez MA; Gutiérrez A; Armand-Ugón M; Blanco J; Parera M; Gómez J; Clotet B; Esté JA
AIDS; 2002 Dec; 16(18):2385-90. PubMed ID: 12461411
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of CXCR4 expression by recombinant adenoviruses containing anti-sense RNA resists HIV-1 infection on MT4 cell lines.
Li WG; Nie WM; Chen WW; Jiang TJ; Xu XY; Zhao M
Gene; 2013 Sep; 526(2):443-8. PubMed ID: 23510780
[TBL] [Abstract][Full Text] [Related]
35. Silencing of CXCR4 by RNA interference inhibits cell growth and metastasis in human renal cancer cells.
Wang L; Huang T; Chen W; Gao X; Zhou T; Wu Z; Sun Y
Oncol Rep; 2012 Dec; 28(6):2043-8. PubMed ID: 22972438
[TBL] [Abstract][Full Text] [Related]
36. [Construction and in vitro antiviral activity of highly effective artificial miRNA targeting to HIV-1 pol].
Cheng T; Zhang T; Zhang Y; Wei L; Xia D; Wang Y; Zhang J; Xia N
Sheng Wu Gong Cheng Xue Bao; 2010 Jan; 26(1):63-73. PubMed ID: 20353094
[TBL] [Abstract][Full Text] [Related]
37. Silencing of HIV-1 gene expression by siRNAs in transduced cells.
Hayafune M; Miyano-Kurosaki N; Takaku H; Park WS
Nucleosides Nucleotides Nucleic Acids; 2006; 25(7):795-9. PubMed ID: 16898417
[TBL] [Abstract][Full Text] [Related]
38. A small-molecule inhibitor directed against the chemokine receptor CXCR4 prevents its use as an HIV-1 coreceptor.
Doranz BJ; Grovit-Ferbas K; Sharron MP; Mao SH; Goetz MB; Daar ES; Doms RW; O'Brien WA
J Exp Med; 1997 Oct; 186(8):1395-400. PubMed ID: 9334380
[TBL] [Abstract][Full Text] [Related]
39. HIV-1 resistance conferred by siRNA cosuppression of CXCR4 and CCR5 coreceptors by a bispecific lentiviral vector.
Anderson J; Akkina R
AIDS Res Ther; 2005 Jan; 2(1):1. PubMed ID: 15813990
[TBL] [Abstract][Full Text] [Related]
40. Imaging-based assay for identification and characterization of inhibitors of CXCR4-tropic HIV-1 envelope-dependent cell-cell fusion.
Kramer S; Buontempo P; Agrawal S; Ralston R
J Biomol Screen; 2011 Jul; 16(6):668-75. PubMed ID: 21474836
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
